Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition
- PMID: 6355296
Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition
Abstract
The mechanism of antibody-dependent complement-(C) mediated killing of Escherichia coli 0111B4, strain 12015 (12015), was examined. 12015 was resistant to serum killing when incubated in hypogammaglobulinemic serum (H gamma S) or pooled normal human serum (NHS) that had been previously adsorbed to remove specific antibody (Abs NHS). Presensitization with immune rabbit serum or purified immune rabbit IgG resulted in 1 to 3 log killing when 5 X 10(8) colony forming units (CFU)/ml were incubated in 10 to 40% Abs NHS. Binding of 125I-C3 and 131I-C9 to the bacterial surface of the presensitized and the nonpresensitized strain was quantitated when these organisms were incubated in 10, 20, and 40% Abs NHS. Stable binding of up to 3.0 X 10(5) molecules of C3 and 8.0 X 10(4) molecules of C9 to presensitized and nonpresensitized isolates occurred in the highest concentration of serum, but there was no killing without presensitization. Similar results were found when Abs NHS was chelated with ethylene bis glycoltetraacetic acid containing 2 mM MgCl2 (Mg EGTA) to block classical pathway activation, indicating that antibody mediated the bactericidal reaction through the alternative pathway. Deposition of C3 and C9 and killing of 120 15 in 10% Abs NHS or 10% H gamma S was measured after presensitization with increasing amounts of IgG, F(ab')2, or Fab'. There was a dose-dependent increase in C3 deposition and killing, but only minimal change in C9 binding when 1.0 X 10(3) to 3.2 X 10(4) IgG or F(ab')2/CFU were bound to the bacterial surface. In contrast, there was no increase in C3 or C9 binding and no bacterial killing when 1 X 10(3) to 3.4 X 10(4) molecules Fab'/CFU were bound to the bacterial surface. These experiments show that immune IgG and F(ab')2 can mediate killing of E. Coli 0111B4 by the alternative pathway without changing the extent of terminal C component attachment to the bacterial surface.
Similar articles
-
Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.J Immunol. 1983 Nov;131(5):2570-5. J Immunol. 1983. PMID: 6355297
-
Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.J Immunol. 1985 May;134(5):3411-9. J Immunol. 1985. PMID: 3920319
-
Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.J Immunol. 1991 Jun 1;146(11):3964-70. J Immunol. 1991. PMID: 2033266
-
Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.Autoimmun Rev. 2008 Jun;7(6):508-13. doi: 10.1016/j.autrev.2008.04.017. Epub 2008 May 12. Autoimmun Rev. 2008. PMID: 18558371 Review.
-
Complement-mediated killing of susceptible gram-negative bacteria: an elusive mechanism.Exp Clin Immunogenet. 1992;9(1):48-56. Exp Clin Immunogenet. 1992. PMID: 1642903 Review.
Cited by
-
Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.Infect Immun. 1984 Jul;45(1):113-7. doi: 10.1128/iai.45.1.113-117.1984. Infect Immun. 1984. PMID: 6203836 Free PMC article.
-
Subversion of the Complement System by Pseudomonas aeruginosa.J Bacteriol. 2023 Aug 24;205(8):e0001823. doi: 10.1128/jb.00018-23. Epub 2023 Jul 12. J Bacteriol. 2023. PMID: 37436150 Free PMC article. Review.
-
Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans.Mol Immunol. 2009 Jan;46(3):473-80. doi: 10.1016/j.molimm.2008.10.008. Epub 2008 Nov 26. Mol Immunol. 2009. PMID: 19038459 Free PMC article.
-
Inhibition of bactericidal activity of anticapsular antibody by nonspecific antibodies reactive with surface-exposed antigenic determinants on Actinobacillus pleuropneumoniae.Infect Immun. 1992 Sep;60(9):3852-60. doi: 10.1128/iai.60.9.3852-3860.1992. Infect Immun. 1992. PMID: 1379990 Free PMC article.
-
Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway.Infect Immun. 1998 Oct;66(10):4845-50. doi: 10.1128/IAI.66.10.4845-4850.1998. Infect Immun. 1998. PMID: 9746588 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous